# Low-glucose/High-fat Intake Dietary Regimen as a Tool for Empowering Diagnostic Accuracy of 2-[18F]FDG PET/CT in Lepidic-predominant Growth Lung Adenocarcinoma

> **NCT07479095** · NA · RECRUITING · sponsor: **Fondazione del Piemonte per l'Oncologia** · enrollment: 30 (estimated)

## Conditions studied

- Lepidic-Predominant Lung Adenocarcinoma
- Lung Adenocarcinoma

## Interventions

- **BEHAVIORAL:** Ketogenic diet
- **DIAGNOSTIC_TEST:** 2-[18F]FDG PET/CT

## Key facts

- **NCT ID:** NCT07479095
- **Lead sponsor:** Fondazione del Piemonte per l'Oncologia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-03
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-03-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07479095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07479095, "Low-glucose/High-fat Intake Dietary Regimen as a Tool for Empowering Diagnostic Accuracy of 2-[18F]FDG PET/CT in Lepidic-predominant Growth Lung Adenocarcinoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07479095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*